(PDF) Hypertension and Overall Survival in Metastatic

Hypertension and Overall Survival in Metastatic Colorectal Cancer Patients Treated With Bevacizumab-Containing Chemotherapy

British Journal of Cancer - United Kingdom

doi 10.1038/bjc.2011.2

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

February 1, 2011

Authors

Publisher

Springer Science and Business Media LLC

Related search

Effect and Safety of Bevacizumab-Containing Chemotherapy Treatment in Chinese Patients With Metastatic Colorectal Cancer

OncoTargets and Therapy

English

Tumor Size and Overall Survival in Patients With Platinum-Resistant Ovarian Cancer Treated With Chemotherapy and Bevacizumab

Clinical Medicine Insights: Oncology

English

Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer

Clinical Colorectal Cancer

Gastroenterology

English

Pretreatment Immune Status Correlates With Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients

Cancer immunology research

Cancer Research

English

Tumoral Cavitation in Colorectal Cancer Patients With Unresectable Lung Metastasis Treated With Bevacizumab and Chemotherapy

Journal of Cancer Research and Clinical Oncology

Cancer Research

English

Perioperative Chemotherapy With or Without Bevacizumab in Patients With Metastatic Colorectal Cancer Undergoing Liver Resection

Clinical Colorectal Cancer

Gastroenterology

English

Bevacizumab Improves Survival in Metastatic Colorectal Cancer Patients With Primary Tumor Resection: A Meta-Analysis

Scientific Reports

Multidisciplinary

English

Cediranib With mFOLFOX6 vs Bevacizumab With mFOLFOX6 in Previously Treated Metastatic Colorectal Cancer

British Journal of Cancer

Cancer Research

English

Utilization of Bevacizumab Among Medicare Patients With Colorectal Cancer Receiving Chemotherapy

Value in Health

Occupational Health

English